These changes obviously point to issues that has transpired at...

These changes obviously point to issues that has transpired at race. Im not smart enough to even speculate what that is. However, I have always been impressed with Dr T's history in shares with previous companies, his drive, passion, understanding of the science and his ability to articulate what that means for our product and patients. I bought in early to this company sub 10c due to my due diligence, wombat and Dr T's 2019 AGM input. I have seen those early gains been depleted (fractional to Dr T). However, despite the paper losses I have never lost sleep and I am more confident than ever with DrT back in a role that drives our product forward in the best way possible